SARS-CoV-2

[Frontiers in Immunology] The authors summarize current evidence from in vitro studies, animal models, and their clinical experience, to support stromal cell therapy in multiple clinical indications.

[Proceedings of the National Academy of Sciences of the United States of America] The authors obtained the extended conformation of the native monomer of SARS-CoV-2 main protease by trapping it with nanobodies, and found that the catalytic domain and the helix domain dissociated, revealing allosteric targets.

[Molecular Medicine] Based on evidence from the literature, as well as international scientific recommendations, the authors review the relationships between COVID-19, autoimmunity and patients with autoimmune rheumatic and musculoskeletal disease.

[Stem Cell Research & Therapy] Investigators focus on the proposed early and late therapeutic mechanisms of human amniotic epithelial cells and their exosomes to the injured organs.

[European Journal of Human Genetics] Investigators discovered an increased allelic expression pattern accompanied with overexpression of human leucocyte antigen (HLA)-B gene in SARS-CoV-2-infected human lung epithelial cells.

[Biotechnology and Bioengineering] Investigators reported the optimization of the production of VSV-ΔG-spike vaccine in Vero cells using the Ambr15 system.